Covidien To Present At J.P. Morgan Healthcare Conference

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the 32 nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2014. Joe Almeida, Chairman, President and Chief Executive Officer, will discuss the company in a presentation scheduled to begin at 8:30 a.m. PT (11:30 a.m. ET).

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.

Copyright Business Wire 2010

If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback